Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults

Conditions

• HIV Infections

Interventions

• BIOLOGICAL: DNA Nat-B env vaccine
• BIOLOGICAL: NYVAC Nat-B env vaccine
• BIOLOGICAL: DNA CON-S env vaccine
• BIOLOGICAL: NYVAC CON-S env vaccine
• BIOLOGICAL: DNA Mosaic env vaccine
• BIOLOGICAL: NYVAC Mosaic env vaccine
• BIOLOGICAL: Placebo
• DEVICE: Biojector 2000® Needle-Free Injection Management System™ (Biojector 2000®)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

• [object Object]
• [object Object]
• [object Object]